Marktprognose für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika bis 2030 – Regionale Analyse – nach Produkt (Reagenzien und Instrumente), Methode (virale Methoden, nicht-virale Methoden und Hybridmethoden), Anwendung (biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung) und Endnutzer (Akademien und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen)
Die zunehmende Popularität der Zell- und Gentherapie stärkt den Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika
Die Herstellung von Zell- und Gentherapien ist ein komplizierter Prozess, dessen Durchführung und Überwachung von entscheidender Bedeutung sind. Fortschritte in der Biotechnologie haben zur Einführung personalisierter Behandlungen für die Behandlung zahlreicher Indikationen geführt. Zell- und Gentherapien werden hauptsächlich zur Behandlung chronischer Krankheiten wie neurologischer Störungen, Krebs und genetischer Störungen eingesetzt. Zu den bemerkenswerten Vorteilen der Zell- und Gentherapie gehören eine gezielte Behandlung, eine schnellere und effizientere Genesung und weniger Nebenwirkungen. Zell- und Gentherapien werden aufgrund der Verfügbarkeit von von der Food and Drug Administration (FDA) zugelassenen Produkten weltweit weithin eingesetzt. So hat die FDA 2022 beispielsweise das von Ferring Pharmaceuticals A/S hergestellte Adenovirus ADSTILADRIN zugelassen. Dieses rekombinante Adenovirus (rAd-IFNa/Syn3) liefert humane Interferon-alfa-2b-cDNA in das Blasenepithel, um Patienten mit bestimmten Arten von Blasenkrebs zu behandeln. 2022 wurde auch CARVYKTI, hergestellt von Janssen Biotech, Inc., von der FDA zugelassen. CARVYKTI ist eine autologe CAR-T-Zelle, die mit Lentiviren entwickelt wurde, um BCMA-exprimierende Tumorzellen anzugreifen und bestimmte Arten von rezidiviertem oder refraktärem multiplem Myelom zu behandeln. Wissenschaftler setzen heutzutage die Transfektionstechnik zur Herstellung dieser Therapien ein. Daher treibt ein Anstieg der Popularität von Zell- und Gentherapieaktivitäten die Zahl der durchgeführten Transfektionsverfahren an, was wiederum das Wachstum des Marktes für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika ankurbelt.
Marktübersicht für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika
Die Region Naher Osten und Afrika ist in Saudi-Arabien, Südafrika, die Vereinigten Arabischen Emirate und den Rest des Nahen Ostens und Afrikas unterteilt. Saudi-Arabien hält im Jahr 2022 den größten Marktanteil.
Das Wachstum der Pharmaindustrie im Nahen Osten und in Afrika wird weitgehend durch Investitionen multinationaler Pharmaunternehmen in Ländern wie Saudi-Arabien, Südafrika, den Vereinigten Arabischen Emiraten und weiteren vorangetrieben. Im Januar 2023 unterzeichnete das saudi-arabische Investitionsministerium zwei Absichtserklärungen zur Verbesserung der gemeinsamen Zusammenarbeit mit der Biotechnologie- und Medizinindustrie im Königreich. Das Ministerium unterzeichnete eine Vereinbarung mit dem deutschen Unternehmen Boehringer Ingelheim zur Stärkung der Pharmaindustrie. Die zweite Absichtserklärung wurde mit Novo Nordisk Saudi-Arabien und der König-Abdullah-Universität für Wissenschaft und Technologie unterzeichnet, mit dem Ziel, Lösungen zur Entwicklung des Bewusstseins der Öffentlichkeit für die Konzepte von Stoffwechselstörungen, Fettleibigkeit und Diabetes bereitzustellen. Solche Bemühungen, die Menschen auf seltene und chronische Erkrankungen aufmerksam zu machen, werden den Markt für Transfektionsreagenzien und -geräte in Saudi-Arabien in den kommenden Jahren wahrscheinlich stärken.
Darüber hinaus treiben Partnerschaften zwischen Unternehmen in diesen Ländern das Marktwachstum voran. Im Dezember 2021 kündigten Secondcell Bio und Alliance Care Technologies International eine neue strategische Partnerschaft zur Gründung einer neuartigen, hochmodernen Forschungseinrichtung an, die sich auf Zelltherapie und schnelle Arzneimittelforschung zur Bekämpfung seltener genetischer Erkrankungen in den VAE konzentriert. Die Chromovert-Technologie ist CRISPR weit voraus und verfügt über ein umfassendes Potenzial, den Prozess der Arzneimittelforschung zu rationalisieren, indem sie die Erzeugung von Zellen ermöglicht, die zuvor für eine verbesserte Arzneimittelforschung entwickelt wurden.
Markt für Transfektionsreagenzien und -geräte im Nahen Osten und in Afrika: Umsatz und Prognose bis 2030 (in Mio. USD)
Marktsegmentierung für Transfektionsreagenzien und -geräte im Nahen Osten und in Afrika
Der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und in Afrika ist nach Produkt, Methode, Anwendung, Endbenutzer und Land segmentiert.
Basierend auf dem Produkt ist der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika in Reagenzien und Instrumente unterteilt. Das Segment Reagenzien hatte 2022 einen größeren Anteil.
In Bezug auf die Methode ist der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika in virale Methoden, nicht-virale Methoden und Hybridmethoden unterteilt. Das Segment der nicht-viralen Methoden hatte 2022 den größten Anteil. Das virale Segment ist in Retroviren, Adenoviren, Adeno-assoziierte Viren und Herpesviren unterteilt. Das nicht-virale Segment ist in physikalische/mechanische Methoden und chemische Methoden unterteilt. Darüber hinaus ist das Segment der physikalischen/mechanischen Methoden in Elektroporation, Mikroinjektion, biolistische Methode, Lasermethode, Magnetofektion und Sonoporation unterteilt. Außerdem ist das Segment der chemischen Methoden in liposomale/lipidreiche und nicht-liposomale/lipidreiche Methoden unterteilt.
Nach Anwendung ist der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika in biomedizinische Forschung, Proteinproduktion und Therapeutikaverabreichung unterteilt. Das Segment biomedizinische Forschung hatte 2022 den größten Anteil.
Basierend auf dem Endverbraucher ist der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika in Hochschulen und Forschungsinstitute sowie Pharma- und Biotechnologieunternehmen unterteilt. Das Segment Hochschulen und Forschungsinstitute hatte 2022 einen größeren Anteil.
Basierend auf dem Land ist der Markt für Transfektionsreagenzien und -geräte im Nahen Osten und Afrika in Südafrika, Saudi-Arabien, die Vereinigten Arabischen Emirate und den Rest des Nahen Ostens und Afrikas unterteilt. Saudi-Arabien dominierte im Jahr 2022 den Markt für Transfektionsreagenzien und -geräte im Nahen Osten und in Afrika.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG und MaxCyte Inc sind einige der führenden Unternehmen auf dem Markt für Transfektionsreagenzien und -geräte im Nahen Osten und in Afrika.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Middle East & Africa Transfection Reagents and Equipment Market Forecast Analysis
6. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East and Africa Transfection Reagents and Equipment Market -Country Analysis
10.1 Middle East and Africa
10.1.1 Middle East and Africa Transfection Reagents and Equipment Market Overview
10.1.2 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.2.3 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.2.4 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.3 South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.3.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.3.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.3.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.3.2.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.3.2.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3.3 South Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.3.4 South Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.4 United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.4.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.4.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.4.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.4.2.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.4.2.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.4.3 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4.4 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.5 Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.5.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.5.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.5.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.5.2.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.5.2.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.5.3 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.5.4 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Thermo Fisher Scientific Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Promega Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bio-Rad Laboratories Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Mirus Bio LLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck KGaA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lonza Group AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 MaxCyte Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
List of Tables
Table 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation
Table 2. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 45. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Middle East and Africa: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.